Tag: NASDAQ:SUPN

Finance

Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Specialist pharmaceutical company Horizon Pharma Inc (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled “Delayed-Release Tablet with Defined Core Geometry” that covers its US approved product RAYOS. Horizon Pharma Inc (NASDAQ:HZNP) stock performance was -7.89% in last session and finished the day at $12.02. Traded volume was 3.88million shares in the last session and the average volume … Continue reading Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Chris Lewis
Finance

Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last session and the average volume of the stock remained 815.19K … Continue reading Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Colin Pettis